CRP test kit

for inflammatory diseasesbloodserum

The kit has been designed for the quantitative determination of C-reactive protein (CRP) in human serum. The method can be used for samples over the range of 0.10-87.50 mg/L. The test has to be performed Taizhou ZECEN Biotech Co., Ltd. model CIA 600, CIA 600Plus, CIA 1200, CIA 1200M, CIA 1800, CIA 2800 and POClia 8, POClia minus, POClia plus, POClia auto automatic chemiluminescence analyzer. Shenzhen IncreCare Biotech Co., Ltd model Shine i1900、Shine i2900 automatic chemiluminescence analyzer. Product Description SUMMARY AND EXPLANATION OF THE TEST C-reactive protein (CRP) detection kit (CLIA) (hereinafter referred to as the kit), is used for the in vitro quantitative determination of C-reactive protein (CRP) concentration in human serum. It can be used to diagnose the infection, tissue damage and inflammatory disease, which can also be used as an adjunct to cardiovascular disease risk identification. C-reactive protein (CRP) is synthesized by hepatocytes in the fetal stage, and not transferred by maternal placental. Its generation mechanism is: when the body is infected or tissue injured, macrophages and other white blood cells are activated to produce interleukin-6 (IL-6), interleukin-1 (IL-1), tumor necrosis factor (TNF-a) other cytokines and other mediators. These cytokines and mediators reach the liver, and stimulate the liver cells and epithelial cells to synthesize CRP. In the structure, CRP contains 5 polypeptide chain subunits, and non-covalent binds into the disc-shaped polymer with a molecular weight of 115,000-140,000. CRP is a typical acute-phase protein.